Rodman & Renshaw initiates coverage on Orthovita (Nasdaq: VITA) with a Market Outperform. Price target $4.

Rodman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE